Effect of particle size on the dissolution behaviors of poorly water-soluble drugs
This study examined the effects of the particle size of various poorly water-soluble drugs on their dissolution behavior through physicochemical and mathematical analysis. As model drugs, hydrochlorothiazide, aceclofenac, ibuprofen and a discovery candidate were selected. The materials were crystall...
Saved in:
Published in | Archives of pharmacal research Vol. 35; no. 7; pp. 1187 - 1195 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Heidelberg
Pharmaceutical Society of Korea
01.07.2012
대한약학회 |
Subjects | |
Online Access | Get full text |
ISSN | 0253-6269 1976-3786 1976-3786 |
DOI | 10.1007/s12272-012-0709-3 |
Cover
Abstract | This study examined the effects of the particle size of various poorly water-soluble drugs on their dissolution behavior through physicochemical and mathematical analysis. As model drugs, hydrochlorothiazide, aceclofenac, ibuprofen and a discovery candidate were selected. The materials were crystallized using an evaporation method and milled without transformation behavior of crystal forms. The particles were sieved and divided into four size groups (< 45 μm, 45∼150 μm, 150∼250 μm, and 250∼600 μm). The specific surface area with regard to the particle size was measured using a BET surface area measurement. The specific surface area increased with decreasing particle size of the drug, resulting in an increase in dissolution rate. During the initial period of the dissolution study, significant differences in dissolution rate were observed according to the particle size and specific surface areas. On the other hand, in the later stages, the surface-specific dissolution rate was almost consistent regardless of the particle size. These observations were evaluated mathematically and the results suggested that the dissolution rate of poorly soluble drugs is strongly related to the particle size distribution. Moreover, physicochemical analysis helped explain the effect of particle size on the dissolution profiles. |
---|---|
AbstractList | This study examined the effects of the particle size of various poorly water-soluble drugs on their dissolution behavior through physicochemical and mathematical analysis. As model drugs, hydrochlorothiazide, aceclofenac, ibuprofen and a discovery candidate were selected. The materials were crystallized using an evaporation method and milled without transformation behavior of crystal forms. The particles were sieved and divided into four size groups (< 45 µm, 45˜¼150 µm, 150˜¼250 µm, and 250˜¼600 µm). The specific surface area with regard to the particle size was measured using a BET surface area measurement. The specific surface area increased with decreasing particle size of the drug, resulting in an increase in dissolution rate. During the initial period of the dissolution study, significant differences in dissolution rate were observed according to the particle size and specific surface areas. On the other hand, in the later stages, the surface-specific dissolution rate was almost consistent regardless of the particle size. These observations were evaluated mathematically and the results suggested that the dissolution rate of poorly soluble drugs is strongly related to the particle size distribution. Moreover, physicochemical analysis helped explain the effect of particle size on the dissolution profiles. This study examined the effects of the particle size of various poorly water-soluble drugs on their dissolution behavior through physicochemical and mathematical analysis. As model drugs, hydrochlorothiazide, aceclofenac, ibuprofen and a discovery candidate were selected. The materials were crystallized using an evaporation method and milled without transformation behavior of crystal forms. The particles were sieved and divided into four size groups (< 45 μm, 45∼150 μm, 150∼250 μm, and 250∼600 μm). The specific surface area with regard to the particle size was measured using a BET surface area measurement. The specific surface area increased with decreasing particle size of the drug, resulting in an increase in dissolution rate. During the initial period of the dissolution study, significant differences in dissolution rate were observed according to the particle size and specific surface areas. On the other hand, in the later stages, the surface-specific dissolution rate was almost consistent regardless of the particle size. These observations were evaluated mathematically and the results suggested that the dissolution rate of poorly soluble drugs is strongly related to the particle size distribution. Moreover, physicochemical analysis helped explain the effect of particle size on the dissolution profiles. This study examined the effects of the particle size of various poorly water-soluble drugs on their dissolution behavior through physicochemical and mathematical analysis. As model drugs, hydrochlorothiazide, aceclofenac, ibuprofen and a discovery candidate were selected. The materials were crystallized using an evaporation method and milled without transformation behavior of crystal forms. The particles were sieved and divided into four size groups (< 45 μm, 45∼150 μm, 150∼250 μm, and 250∼600 μm). The specific surface area with regard to the particle size was measured using a BET surface area measurement. The specific surface area increased with decreasing particle size of the drug, resulting in an increase in dissolution rate. During the initial period of the dissolution study, significant differences in dissolution rate were observed according to the particle size and specific surface areas. On the other hand, in the later stages, the surface-specific dissolution rate was almost consistent regardless of the particle size. These observations were evaluated mathematically and the results suggested that the dissolution rate of poorly soluble drugs is strongly related to the particle size distribution. Moreover, physicochemical analysis helped explain the effect of particle size on the dissolution profiles.This study examined the effects of the particle size of various poorly water-soluble drugs on their dissolution behavior through physicochemical and mathematical analysis. As model drugs, hydrochlorothiazide, aceclofenac, ibuprofen and a discovery candidate were selected. The materials were crystallized using an evaporation method and milled without transformation behavior of crystal forms. The particles were sieved and divided into four size groups (< 45 μm, 45∼150 μm, 150∼250 μm, and 250∼600 μm). The specific surface area with regard to the particle size was measured using a BET surface area measurement. The specific surface area increased with decreasing particle size of the drug, resulting in an increase in dissolution rate. During the initial period of the dissolution study, significant differences in dissolution rate were observed according to the particle size and specific surface areas. On the other hand, in the later stages, the surface-specific dissolution rate was almost consistent regardless of the particle size. These observations were evaluated mathematically and the results suggested that the dissolution rate of poorly soluble drugs is strongly related to the particle size distribution. Moreover, physicochemical analysis helped explain the effect of particle size on the dissolution profiles. This study examined the effects of the particle size of various poorly water-soluble drugs on their dissolution behavior through physicochemical and mathematical analysis. As model drugs, hydrochlorothiazide, aceclofenac, ibuprofen and a discovery candidate were selected. The materials were crystallized using an evaporation method and milled without transformation behavior of crystal forms. The particles were sieved and divided into four size groups (< 45 μm, 45~150 μm, 150~250 μm, and 250~600 μm). The specific surface area with regard to the particle size was measured using a BET surface area measurement. The specific surface area increased with decreasing particle size of the drug, resulting in an increase in dissolution rate. During the initial period of the dissolution study, significant differences in dissolution rate were observed according to the particle size and specific surface areas. On the other hand, in the later stages, the surface-specific dissolution rate was almost consistent regardless of the particle size. These observations were evaluated mathematically and the results suggested that the dissolution rate of poorly soluble drugs is strongly related to the particle size distribution. Moreover, physicochemical analysis helped explain the effect of particle size on the dissolution profiles. KCI Citation Count: 56 |
Author | Chu, Kyung Rok Jeong, Seong Hoon Lee, Eunhee Park, Eun-Seok |
Author_xml | – sequence: 1 givenname: Kyung Rok surname: Chu fullname: Chu, Kyung Rok organization: College of Pharmacy, Pusan National University – sequence: 2 givenname: Eunhee surname: Lee fullname: Lee, Eunhee organization: College of Pharmacy, Korea University – sequence: 3 givenname: Seong Hoon surname: Jeong fullname: Jeong, Seong Hoon email: shjeong@dongguk.edu organization: College of Pharmacy, Dongguk University-Seoul – sequence: 4 givenname: Eun-Seok surname: Park fullname: Park, Eun-Seok organization: School of Pharmacy, Sungkyunkwan University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22864741$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001682636$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNqFkU1P3DAQhq2Kqiy0P6CXKsdyCPVX7OSI0PIhISEherYce7wYsvHWdqjor8chlEMP9GCNLD3veMbPAdobwwgIfSX4mGAsfyRCqaQ1JuVI3NXsA1qRToqayVbsoRWmDasFFd0-OkjpHmMmmqb5hPYpbQWXnKzQzdo5MLkKrtrpmL0ZoEr-D1RhrPIdVNanFIYp-3Lv4U4_-hDTCx1CHJ6q3zpDrGekL0kbp036jD46PST48loP0c-z9e3pRX11fX55enJVGy5lrntnTJkPJBe4A8sBekwpJbSVjcWalN0wc7q13HWNkLZrtLWcOUEktw5TdoiOlr5jdOrBeBW0f6mboB6iOrm5vVSEMElZU9jvC7uL4dcEKautTwaGQY8QpqSIZIWiLSf_RzGjZWLasYJ-e0WnfgtW7aLf6vik_n5vAcgCmBhSiuDeEILVrFAtClVRqGaFam4q_8kYn_UsIEfth3eTdEmm8sq4gajuwxTH4uCd0DNKBq20 |
CitedBy_id | crossref_primary_10_1107_S2053229621012171 crossref_primary_10_1016_j_powtec_2016_05_065 crossref_primary_10_1002_anie_201307653 crossref_primary_10_3390_pharmaceutics14102173 crossref_primary_10_1080_17436753_2019_1706825 crossref_primary_10_3390_pharmaceutics14071504 crossref_primary_10_1186_s43094_021_00271_x crossref_primary_10_3390_cryst12111565 crossref_primary_10_22159_ijap_2022v14i6_45975 crossref_primary_10_28979_jarnas_1448999 crossref_primary_10_1016_j_ijpharm_2024_124863 crossref_primary_10_1016_j_ejps_2014_11_012 crossref_primary_10_1088_1757_899X_736_6_062008 crossref_primary_10_1208_s12249_020_01701_4 crossref_primary_10_1007_s12247_020_09526_1 crossref_primary_10_1016_j_ejpb_2024_114480 crossref_primary_10_1016_j_trac_2014_01_008 crossref_primary_10_1089_jamp_2024_0036 crossref_primary_10_1039_D2EM00163B crossref_primary_10_1007_s13346_017_0362_y crossref_primary_10_1016_j_powtec_2022_117329 crossref_primary_10_1111_bcp_14977 crossref_primary_10_1155_2014_929248 crossref_primary_10_1208_s12249_013_9948_y crossref_primary_10_1021_acs_cgd_0c00469 crossref_primary_10_33320_maced_pharm_bull_2022_68_03_125 crossref_primary_10_1021_acsomega_1c06708 crossref_primary_10_1680_jbibn_21_00065 crossref_primary_10_1007_s12247_020_09530_5 crossref_primary_10_1039_C8RA02106F crossref_primary_10_1016_j_ijpharm_2023_123681 crossref_primary_10_1039_D0CP04498A crossref_primary_10_3109_03639045_2013_858739 crossref_primary_10_1016_j_ijpharm_2020_119809 crossref_primary_10_1016_j_jddst_2025_106726 crossref_primary_10_1177_15593258221097594 crossref_primary_10_1016_j_colcom_2021_100536 crossref_primary_10_1016_j_ejpb_2019_01_010 crossref_primary_10_1007_s40005_020_00486_9 crossref_primary_10_1021_acs_molpharmaceut_8b00505 crossref_primary_10_1515_gps_2022_8107 crossref_primary_10_1016_j_ijpharm_2022_122502 crossref_primary_10_1016_j_apt_2021_05_040 crossref_primary_10_1021_acs_iecr_3c00811 crossref_primary_10_1111_jfpe_13729 crossref_primary_10_3390_pharmaceutics15122650 crossref_primary_10_3109_03639045_2015_1135936 crossref_primary_10_1016_j_cherd_2024_05_034 crossref_primary_10_52711_0974_360X_2023_00436 crossref_primary_10_1016_j_jcrysgro_2021_126263 crossref_primary_10_3390_polym13234072 crossref_primary_10_7317_pk_2015_39_1_6 crossref_primary_10_1002_ange_201307653 crossref_primary_10_1080_03639045_2024_2321388 crossref_primary_10_1016_j_jconrel_2022_05_006 crossref_primary_10_3390_pharmaceutics15102446 crossref_primary_10_1208_s12249_020_01811_z crossref_primary_10_34172_PS_2019_52 crossref_primary_10_1002_ps_5573 crossref_primary_10_1007_s11095_024_03696_0 crossref_primary_10_1039_C5RA08318D crossref_primary_10_1039_c3ce40938d crossref_primary_10_1016_j_colsurfb_2020_110946 crossref_primary_10_1016_j_jiec_2021_05_032 crossref_primary_10_1002_jctb_7497 crossref_primary_10_1007_s12272_013_0180_9 crossref_primary_10_3390_pharmaceutics14051107 crossref_primary_10_1208_s12249_021_01962_7 crossref_primary_10_1007_s12247_018_9319_z crossref_primary_10_1016_j_xphs_2019_03_013 crossref_primary_10_1021_acs_cgd_9b00200 crossref_primary_10_1016_j_ejpb_2021_12_004 crossref_primary_10_1016_j_ijpharm_2024_124010 crossref_primary_10_3390_pharmaceutics11040173 crossref_primary_10_3390_cryst12040550 crossref_primary_10_1016_j_ijpharm_2023_123580 crossref_primary_10_1080_10837450_2021_1872087 crossref_primary_10_1080_10837450_2023_2231074 |
Cites_doi | 10.1002/jps.2600520310 10.1021/ja02086a003 10.1016/S0939-6411(00)00091-6 10.1016/0378-5173(95)00033-F 10.1016/0039-9140(94)00243-L 10.1016/S0378-5173(03)00005-X 10.1016/S0169-409X(97)00507-3 10.1016/0378-5173(95)04102-8 10.1002/jps.10480 10.1007/s10337-011-2111-6 10.1021/ie50260a018 10.1007/s12272-011-0511-7 10.1016/0378-5173(88)90235-9 10.1016/0378-5173(95)04312-8 10.1515/zpch-1904-4705 10.1358/mf.1998.20.3.485666 10.1515/zpch-1904-4704 |
ContentType | Journal Article |
Copyright | The Pharmaceutical Society of Korea and Springer Netherlands 2012 |
Copyright_xml | – notice: The Pharmaceutical Society of Korea and Springer Netherlands 2012 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 ACYCR |
DOI | 10.1007/s12272-012-0709-3 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1976-3786 |
EndPage | 1195 |
ExternalDocumentID | oai_kci_go_kr_ARTI_1137235 22864741 10_1007_s12272_012_0709_3 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -53 -56 -5G -BR -EM -Y2 -~C .86 .UV .VR 06C 06D 0R~ 0VY 1N0 2.D 203 23N 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2WC 2~H 30V 3SX 4.4 406 408 40D 40E 53G 5GY 5VS 67N 67Z 6J9 6NX 8TC 8UJ 95- 95. 95~ 96X 9ZL AAAVM AABHQ AACDK AAHBH AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHQN ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABWNU ABXPI ACAOD ACBXY ACDTI ACGFO ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACREN ACSNA ACUDM ACZOJ ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFGCZ AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BGNMA C1A CAG COF CS3 CSCUP DDRTE DNIVK DPUIP EBLON EBS EIOEI EJD EMOBN ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GRRUI H13 HF~ HG6 HMJXF HRMNR HVGLF HZ~ IJ- IKXTQ IWAJR IXC IXD I~X I~Z J-C J0Z JBSCW JZLTJ KOV KPH KVFHK LLZTM M4Y MA- MZR N2Q N9A NDZJH NF0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OVD P19 P2P PF0 PT4 PT5 QOK QOR QOS R89 R9I RHV RNI RNS ROL RPX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SCLPG SDE SDH SHX SISQX SJN SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZ9 SZN T13 T16 TEORI TSG TSK TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W48 WK6 WK8 YLTOR Z45 Z7U Z7V Z7W Z83 Z87 Z8O Z8P Z8Q Z91 ZMTXR ZOVNA ZZE ~A9 AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 AABYN AAFGU AAKSU AAPBV AAYFA ABFGW ABKAS ACBMV ACBRV ACBYP ACIGE ACIPQ ACTTH ACVWB ACWMK ACYCR ADMDM ADOXG AEEQQ AEFTE AESTI AEVTX AFAFS AFNRJ AGGBP AGKHE AIMYW AJDOV AKQUC UNUBA Z7X |
ID | FETCH-LOGICAL-c477t-bfcc253e74609ed4eeb022212875d0a112203fa8d4f9567d95add43f6174df023 |
IEDL.DBID | AGYKE |
ISSN | 0253-6269 1976-3786 |
IngestDate | Tue Nov 21 21:44:09 EST 2023 Fri Sep 05 11:11:52 EDT 2025 Mon Jul 21 10:58:02 EDT 2025 Mon Jul 21 05:56:03 EDT 2025 Wed Oct 01 04:24:50 EDT 2025 Thu Apr 24 23:08:51 EDT 2025 Fri Feb 21 02:37:01 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Specific surface area Particle size Hixson-Crowell plot Poorly water soluble drugs Dissolution Mean dissolution time |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c477t-bfcc253e74609ed4eeb022212875d0a112203fa8d4f9567d95add43f6174df023 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-000010.2012.35.7.007 |
PMID | 22864741 |
PQID | 1032609293 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_1137235 proquest_miscellaneous_1733532841 proquest_miscellaneous_1032609293 pubmed_primary_22864741 crossref_primary_10_1007_s12272_012_0709_3 crossref_citationtrail_10_1007_s12272_012_0709_3 springer_journals_10_1007_s12272_012_0709_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20120700 2012-7-00 2012-Jul 20120701 2012-07 |
PublicationDateYYYYMMDD | 2012-07-01 |
PublicationDate_xml | – month: 7 year: 2012 text: 20120700 |
PublicationDecade | 2010 |
PublicationPlace | Heidelberg |
PublicationPlace_xml | – name: Heidelberg – name: Korea (South) |
PublicationTitle | Archives of pharmacal research |
PublicationTitleAbbrev | Arch. Pharm. Res |
PublicationTitleAlternate | Arch Pharm Res |
PublicationYear | 2012 |
Publisher | Pharmaceutical Society of Korea 대한약학회 |
Publisher_xml | – name: Pharmaceutical Society of Korea – name: 대한약학회 |
References | Anderberg (CR1) 1992; 91 Brunner (CR4) 1904; 47 Brockmeier (CR3) 1986; 32 Noyes, Whitney (CR17) 1897; 19 Rasenack, Hartenhauer, Müller (CR20) 2003; 254 Coudoré, Harvard, Lefeuvre, Billaud, Beaune, Bobrie, Azizi, Prognon, Laurent (CR9) 2011; 74 Löbenberg, Amidon (CR13) 2000; 50 Hixson, Crowell (CR11) 1931; 23 Bisrat, Nyström (CR2) 1988; 47 CR18 Nernst (CR15) 1904; 47 Simões, Sousa, Figueiredo (CR21) 1996; 127 Kim, Sohn (CR12) 2011; 34 Mosharraf, Nyström (CR14) 1995; 122 Posac, Vázquez, Tascón, Acuña, de la Fuente, Velasco, Sánchez-Batanero (CR19) 1995; 42 Cao, Mullarney, Hancock, Bates, Morris (CR6) 2003; 92 Cospite, Dominici (CR8) 1989; 8 Chaumeil (CR7) 1998; 20 Fini, Fazio, Feroci (CR10) 1995; 126 Niebergall, Milsovich, Goyan (CR16) 1963; 52 Buckton (CR5) 1997; 26 A. W. Hixson (709_CR11) 1931; 23 R. Löbenberg (709_CR13) 2000; 50 D. Brockmeier (709_CR3) 1986; 32 A. Fini (709_CR10) 1995; 126 F. Coudoré (709_CR9) 2011; 74 E. K. Anderberg (709_CR1) 1992; 91 P. J. Niebergall (709_CR16) 1963; 52 G. Buckton (709_CR5) 1997; 26 J. C. Chaumeil (709_CR7) 1998; 20 M. Cospite (709_CR8) 1989; 8 N. Rasenack (709_CR20) 2003; 254 S. Simões (709_CR21) 1996; 127 B. Y. Kim (709_CR12) 2011; 34 M. Bisrat (709_CR2) 1988; 47 E. Brunner (709_CR4) 1904; 47 W. Cao (709_CR6) 2003; 92 M. Mosharraf (709_CR14) 1995; 122 A. Noyes (709_CR17) 1897; 19 W. Nernst (709_CR15) 1904; 47 J. R. Posac (709_CR19) 1995; 42 709_CR18 |
References_xml | – volume: 52 start-page: 236 year: 1963 end-page: 241 ident: CR16 article-title: Dissolution rate studies: II. Dissolution of particles under conditions of rapid agitation publication-title: J. Pharm. Sci. doi: 10.1002/jps.2600520310 – ident: CR18 – volume: 19 start-page: 930 year: 1897 end-page: 934 ident: CR17 article-title: The rate of solution of solid substances in their own solutions publication-title: J. Am. Chem. Soc. doi: 10.1021/ja02086a003 – volume: 50 start-page: 3 year: 2000 end-page: 12 ident: CR13 article-title: Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/S0939-6411(00)00091-6 – volume: 122 start-page: 35 year: 1995 end-page: 47 ident: CR14 article-title: The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs publication-title: Int. J. Pharm. doi: 10.1016/0378-5173(95)00033-F – volume: 42 start-page: 293 year: 1995 end-page: 304 ident: CR19 article-title: Determination of aceclofenac using adsorptive stripping voltammetric techniques on conventional and surfactant chemically modified carbon paste electrodes publication-title: Talanta doi: 10.1016/0039-9140(94)00243-L – volume: 91 start-page: 8 year: 1992 ident: CR1 article-title: Studies on the dissolution of fine particulate practically insoluble drugs and on the effect of surface active enhancers on gastrointestinal absorption of hydrophilic drugs publication-title: Acta Univ. Ups. – volume: 254 start-page: 137 year: 2003 end-page: 145 ident: CR20 article-title: Microcrystals for dissolution rate enhancement of poorly watersoluble drugs publication-title: Int. J. Pharm. doi: 10.1016/S0378-5173(03)00005-X – volume: 26 start-page: 17 year: 1997 end-page: 27 ident: CR5 article-title: Characterization of small changes in the physical properties of powders of significance for dry powder inhaler formulations publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/S0169-409X(97)00507-3 – volume: 126 start-page: 95 year: 1995 end-page: 102 ident: CR10 article-title: Solubility and solubilization properties of non-steroidal anti-inflammatory drugs publication-title: Int. J. Pharm. doi: 10.1016/0378-5173(95)04102-8 – volume: 20 start-page: 211 year: 1998 end-page: 215 ident: CR7 article-title: Micronization: A method of improving the bioavailability of poorly soluble drugs publication-title: Methods Find. Exp. Clin. Pharmacol. – volume: 92 start-page: 2345 year: 2003 end-page: 2353 ident: CR6 article-title: Modeling of transmitted X-ray intensity variation with sample thickness and solid fraction in glycine compacts publication-title: J. Pharm. Sci. doi: 10.1002/jps.10480 – volume: 47 start-page: 52 year: 1904 end-page: 55 ident: CR15 article-title: Theorie der Reaktionsgeschwindigkeit in heterogenen Systemen publication-title: Z. Phys. Chem. – volume: 8 start-page: 61 year: 1989 end-page: 65 ident: CR8 article-title: Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form publication-title: Int. Angiol. – volume: 32 start-page: 164 year: 1986 end-page: 174 ident: CR3 article-title: / correlation of dissolution using moments of dissolution and transit times publication-title: Acta Pharm. Technol. – volume: 74 start-page: 559 year: 2011 end-page: 565 ident: CR9 article-title: HPLC-DAD Analysis of Hydrochlorothiazide and Irbesartan in Hypertensive Patients on Fixed-Dose Combination Therapy publication-title: Chromatographia doi: 10.1007/s10337-011-2111-6 – volume: 23 start-page: 923 year: 1931 end-page: 931 ident: CR11 article-title: Dependence of reaction velocity upon surface and agitation. I Theoretical consideration publication-title: Ind. Eng. Chem. doi: 10.1021/ie50260a018 – volume: 47 start-page: 56 year: 1904 end-page: 102 ident: CR4 article-title: Theorie der Reaktionsgeschwindigkeit in heterogenen systemen publication-title: Z. Phys. Chem. (N F) – volume: 34 start-page: 775 year: 2011 end-page: 779 ident: CR12 article-title: Solid state of CG-400549, a novel FabI inhibitor: Characterization, dissolution, transformation publication-title: Arch. Pharm. Res. doi: 10.1007/s12272-011-0511-7 – volume: 47 start-page: 223 year: 1988 end-page: 231 ident: CR2 article-title: Physicochemical aspects of drug release: VIII. The relation between particle size and surface specific dissolution rate in agitated suspensions publication-title: Int. J. Pharm. doi: 10.1016/0378-5173(88)90235-9 – volume: 127 start-page: 283 year: 1996 end-page: 291 ident: CR21 article-title: Dissolution rate studies of pharmaceutical multisized powders — a practical approach using the Coulter method publication-title: Int. J. Pharm. doi: 10.1016/0378-5173(95)04312-8 – volume: 91 start-page: 8 year: 1992 ident: 709_CR1 publication-title: Acta Univ. Ups. – volume: 47 start-page: 56 year: 1904 ident: 709_CR4 publication-title: Z. Phys. Chem. (N F) doi: 10.1515/zpch-1904-4705 – volume: 23 start-page: 923 year: 1931 ident: 709_CR11 publication-title: Ind. Eng. Chem. doi: 10.1021/ie50260a018 – ident: 709_CR18 – volume: 52 start-page: 236 year: 1963 ident: 709_CR16 publication-title: J. Pharm. Sci. doi: 10.1002/jps.2600520310 – volume: 19 start-page: 930 year: 1897 ident: 709_CR17 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja02086a003 – volume: 122 start-page: 35 year: 1995 ident: 709_CR14 publication-title: Int. J. Pharm. doi: 10.1016/0378-5173(95)00033-F – volume: 127 start-page: 283 year: 1996 ident: 709_CR21 publication-title: Int. J. Pharm. doi: 10.1016/0378-5173(95)04312-8 – volume: 26 start-page: 17 year: 1997 ident: 709_CR5 publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/S0169-409X(97)00507-3 – volume: 74 start-page: 559 year: 2011 ident: 709_CR9 publication-title: Chromatographia doi: 10.1007/s10337-011-2111-6 – volume: 42 start-page: 293 year: 1995 ident: 709_CR19 publication-title: Talanta doi: 10.1016/0039-9140(94)00243-L – volume: 32 start-page: 164 year: 1986 ident: 709_CR3 publication-title: Acta Pharm. Technol. – volume: 34 start-page: 775 year: 2011 ident: 709_CR12 publication-title: Arch. Pharm. Res. doi: 10.1007/s12272-011-0511-7 – volume: 50 start-page: 3 year: 2000 ident: 709_CR13 publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/S0939-6411(00)00091-6 – volume: 92 start-page: 2345 year: 2003 ident: 709_CR6 publication-title: J. Pharm. Sci. doi: 10.1002/jps.10480 – volume: 8 start-page: 61 year: 1989 ident: 709_CR8 publication-title: Int. Angiol. – volume: 126 start-page: 95 year: 1995 ident: 709_CR10 publication-title: Int. J. Pharm. doi: 10.1016/0378-5173(95)04102-8 – volume: 47 start-page: 223 year: 1988 ident: 709_CR2 publication-title: Int. J. Pharm. doi: 10.1016/0378-5173(88)90235-9 – volume: 254 start-page: 137 year: 2003 ident: 709_CR20 publication-title: Int. J. Pharm. doi: 10.1016/S0378-5173(03)00005-X – volume: 20 start-page: 211 year: 1998 ident: 709_CR7 publication-title: Methods Find. Exp. Clin. Pharmacol. doi: 10.1358/mf.1998.20.3.485666 – volume: 47 start-page: 52 year: 1904 ident: 709_CR15 publication-title: Z. Phys. Chem. doi: 10.1515/zpch-1904-4704 |
SSID | ssj0036555 |
Score | 2.2913618 |
Snippet | This study examined the effects of the particle size of various poorly water-soluble drugs on their dissolution behavior through physicochemical and... |
SourceID | nrf proquest pubmed crossref springer |
SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1187 |
SubjectTerms | Chemistry, Pharmaceutical Crystallization Diclofenac - analogs & derivatives Diclofenac - chemistry evaporation hydrochlorothiazide Hydrochlorothiazide - chemistry ibuprofen Ibuprofen - chemistry Kinetics Medicine Models, Chemical Particle Size particle size distribution Pharmacology/Toxicology Pharmacy Solubility Solvents - chemistry surface area Surface Properties Technology, Pharmaceutical - methods Water - chemistry 약학 |
Title | Effect of particle size on the dissolution behaviors of poorly water-soluble drugs |
URI | https://link.springer.com/article/10.1007/s12272-012-0709-3 https://www.ncbi.nlm.nih.gov/pubmed/22864741 https://www.proquest.com/docview/1032609293 https://www.proquest.com/docview/1733532841 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001682636 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Archives of Pharmacal Research, 2012, 35(7), , pp.1187-1195 |
journalDatabaseRights | – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1976-3786 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036555 issn: 0253-6269 databaseCode: AFBBN dateStart: 19970201 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVAVX databaseName: SpringerLINK - Czech Republic Consortium customDbUrl: eissn: 1976-3786 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036555 issn: 0253-6269 databaseCode: AGYKE dateStart: 19970101 isFulltext: true titleUrlDefault: http://link.springer.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1976-3786 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0036555 issn: 0253-6269 databaseCode: U2A dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fa9swED6aFMZetrbbuuxH0cbow1YVR5Kt-jGUdt1GRxkJdE_C1o9SUuxiJ4z0r98plhq2dYU--cFnI5-_033HSZ8APnCeZl7YjCYs11TolNHcpRnF4LDIToZGDP1G4dPv2clEfD1Pz8M-7jaudo8tyeVMvdrsxpj0ywj8aknfsO_Beurrkz6sjz7__HYUJ2CepcvDTjGbc4p8PY_NzLte8kc66lWNu4tp_tMlXSaf46cwjsPu1pxM9-ezcl_f_KXo-MDv2oAngYySUYeeTViz1RY8Og3t9i3YPeuErRd7ZLzap9XukV1ytpK8XjyDH50IMqkduQ5YJO3ljSV1RZBhEt_1DxgnURigXVrXdXO1IL-Q8TbUm5T4pGnmF-1zmBwfjQ9PaDitgWoh5YyWTmv0uJUiS3JrhLWlLyYx_8nUJAXyOpZwVxwY4bAmkyZPcWoV3CGFEsYhdXgB_aqu7Esg1mRaCMcMskOvZ19gKBuO-VbYokhMNoAk_jSlg5S5P1HjSq1EmL1TFTpVeacqPoCPt49cdzoe9xm_RySoqb5UXn3bXy9qNW0U1hhfsGbikvF0AO8iUBSGpO-zFJWt563yGoXoAyRS99hIjBKO3GA4gO0OZbfjYuwgE9Lf-RQRo8LM0v5_0K8eZP0aHrMOcoi8N9CfNXP7FunVrNwJ4bQDvQkb_QZ3NBfT |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fT9swED6NIm17YRv71Q02b5p4GBilthM3jwjByqAITUViT1biHwgVJShphcpfv3PjUI0xJJ7ykEvkXL7zfdadPwN84zxOvLAZjViqqdAxo6mLE4rBYZGd9Izo-Y3Cw-NkcCp-nsVnYR933Xa7tyXJ-Uy92OzGmPRtBL5b0hfsl2BZ9Pp90YHlnR-_D_faCZgn8fywU8zmnCJfT9ti5n0v-SsdLRWVu49p_lMlnSef_Rcwaofd9JyMt6eTfFvf3FF0fOR3vYSVQEbJToOeV_DEFqvwdBjK7auwcdIIW8-2yGixT6veIhvkZCF5PXsNvxoRZFI6chWwSOqLG0vKgiDDJL7qHzBOWmGAem5dltXljFwj462oN8nxSVNNz-s3cLq_N9od0HBaA9VCygnNndbocStFEqXWCGtzv5jE_CdjE2XI61jEXdY3wuGaTJo0xqlVcIcUShiH1OEtdIqysO-BWJNoIRwzyA69nn2GoWw45lthsywySRei9qcpHaTM_Ykal2ohwuydqtCpyjtV8S58v33kqtHxeMj4KyJBjfWF8urb_npeqnGlcI1xgGsmLhmPu_ClBYrCkPR1lqyw5bRWXqMQfYBE6gEbiVHCkRv0uvCuQdntuBjrJ0L6O5stYlSYWer_D_rDo6w_w7PBaHikjg6ODz_Cc9bAD1G4Bp1JNbXrSLUm-acQWn8ANc0Z2w |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS-QwEB90D8QX8fTUPe8jyuHDabCbpI19lDsXP05ZDhd8C90mEXFpl3aXY_3rndm2Locf4FMfOiklM5P5DZP5DcAPKcOIiM14IOKUqzQUPPZhxNE5HKKTjlUdahS-vIpO--r8Jryp55yWzW33piRZ9TQQS1M2PhxZfzhvfBNC05UCujlJxftF-KAwVFP21RfHzVEso3A29hTjuuSI3OOmrPnSJ_4LTItZ4V_CnM_qpbMw1F2FlRo_suNK4R9hwWVrsHRZV8jXYK9XcVFPD9j1vLWqPGB7rDdnqZ6uw9-Kt5jlno1q82Hl3YNjecYQFDIq1NdmyZpe_nImnefFcMr-IUgtOIkMcKUtJrflJ-h3T65_nfJ6wAJPldZjPvBpilvjtIqC2Fnl3IDyPwxZOrRBglBMBNInR1Z5TKO0jUM8DZX0iHqU9RjtN6CV5ZnbAuZslCrlhUVARxT0CXqflRgilUuSwEZtCJrdNWnNPk5DMIZmzptMCjGoEEMKMbINP5-WjCrqjbeEd1Fl5j69M0SYTc_b3NwXBtOCM0xzpBYybMNOo1GDXkSlkSRz-aQ0RCuIe4DY5w0ZjYYtMZx32rBZmcPTfwlxFClNb_Yb-zD1YVC-_tOf3yX9HZZ6v7vmz9nVxTYsi8py0YC_QGtcTNxXBEfjwbeZAzwCny4BXA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+particle+size+on+the+dissolution+behaviors+of+poorly+water-soluble+drugs&rft.jtitle=Archives+of+pharmacal+research&rft.au=Chu%2C+Kyung+Rok&rft.au=Lee%2C+Eunhee&rft.au=Jeong%2C+Seong+Hoon&rft.au=Park%2C+Eun-Seok&rft.date=2012-07-01&rft.pub=Pharmaceutical+Society+of+Korea&rft.issn=0253-6269&rft.eissn=1976-3786&rft.volume=35&rft.issue=7&rft.spage=1187&rft.epage=1195&rft_id=info:doi/10.1007%2Fs12272-012-0709-3&rft.externalDocID=10_1007_s12272_012_0709_3 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0253-6269&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0253-6269&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0253-6269&client=summon |